Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: August 2017

HINJ’s ‘Value of Medical Innovation’ Portal Showcases How Life Sciences Is Saving Money — And Lives

New Brunswick, NJ, August 25, 2017 ― The HealthCare Institute of New Jersey (HINJ) continues to update its Value of Medical Innovation, a fact-driven, consumer-friendly digital library that delves into the myriad benefits of research-driven medical innovation, which saves money — and saves lives.

Introduced in September 2015, HINJ’s Value of Medical Innovation presents statistics from a number of resources, including the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA), U.S. government sources and various medical research organizations. Continue reading

Rutgers Scientists Working on CRISPR Technology That Could, Literally, Change the World

New Brunswick, NJ, August 25, 2017 — CRISPR…what’s that?  Senior correspondent David Cruz reports on “NJTV News” that CRISPR is emerging technology that you might be hearing about it yet have little understanding that it has the potential to change pretty much everything and everyone in the world.

Peter Romanienko, the managing director of the Genome Editing Core Facility at Rutgers University, explained, “CRISPR is a programmable nucleus, so the power of it is.

And what makes it work so well for gene editing and some of the techniques we use is this protein can use this small segment of RNA to find a site in the genome and cut it.  And by making this DNA break in the genome is what allows us to introduce sequences and repair.” Continue reading

Opinion: BIO CEO Jim Greenwood on ‘Don’t Let Fear Trump Science – Vaccinate Your Child’

Jim Greenwood

Washington, DC, August 24, 2017Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood wrote the following op-ed that was published in The Philadelphia Inquirer on August 23:

The nice lady had sugar cubes. My classmates and I lined up, single file, at Richboro Elementary School more than half a century ago, waiting for our taste. For a kid, it was a serendipitous moment — our parents were actually ordering us to consume sweets to keep us healthy.

These were no ordinary sugar cubes, though. We were in line to take the new oral polio vaccine. Continue reading

William Paterson University President to Step Down After 2017-2018 Academic Year

Kathleen Waldron

Wayne, NJ, August 24, 2017 — Kathleen Waldron, who has led strategic initiatives that have enhanced academics and infrastructure at William Paterson University, on August 22 announced that she will retire at the end of the 2017-18 academic year after eight years as president of the institution.

President Waldron plans to retire effective June 30, 2018.  The University’s Board of Trustees has launched a national search for a new president.

“I will turn 70 years old in September 2018 and have had the great honor of being an academic administrator for 20 years,” says President Waldron, who became the institution’s seventh president on August 2, 2010. Continue reading

Modern Healthcare Names 100 Most Influential People in Healthcare 2017; Senators Collins, McCain and Murkowski Top List

Senators Susan Collins, John McCain and Lisa Murkowski

Washington, DC, August 24, 2017 — Harris Meyer reports in Modern Healthcare that three Republican senators — Maine’s Susan Collins, Alaska’s Lisa Murkowski and Arizona’s John McCain — decided their party’s bill to repeal the Affordable Care Act would be bad for the states they represent.

Resisting tremendous political pressure, the three voted against Senate Majority Leader Mitch McConnell’s stripped-down ACA repeal bill.

In doing so, they dramatically reshaped the epic political battle over the future of the ACA, which has been bitterly fought over by Republicans and Democrats since it was passed by Democrats on a party-line vote in March 2010. Continue reading

Rutgers Cancer Institute and National Cancer Institute Scientists’ DNA Repair Research Bolstered with $4 Million in Multi-Source Support

New Brunswick, NJ, August 23, 2017 — Cancer researchers have learned that by sharing their knowledge and forming strategic partnerships, they can more rapidly advance their discoveries leading to drug development, clinical trials and ultimately new therapies for cancer patients.

Thanks to $4 million in combined support, including $2 million in funding from the Robert Wood Johnson Foundation, physician-scientists at Rutgers Cancer Institute of New Jersey are embarking on a new collaboration with the National Cancer Institute’s (NCI) intramural Center for Cancer Research (CCR). NCI is part of the National Institutes of Health. Continue reading

Op-Ed: NJ Assn. of State Colleges and Universities’ Dr. Michael Klein Urges ‘Modernize Contracts Laws for NJ’s State Colleges, Universities’

Dr. Michael Klein

Trenton, NJ, August 23, 2017NJ Spotlight on August 14 published the following op-ed by Michael W. Klein, J.D., Ph.D., executive director of the New Jersey Association of State Colleges and Universities:

The ideal college, according to President James Garfield, was having Mark Hopkins, the president of Williams College from 1836 to 1872, “on one end of a log and a student on the other.”

Times have changed a bit since Garfield graduated from Williams in 1856. To be sure, professors and their classrooms are important, but so too are libraries, laboratories, computers, and high-speed connections to the Internet.  Continue reading

Rutgers RWJ’s Dr. Gaurav Gupta Puts a 3D-Printed Skull Bone into Patient’s Head

Dr. Gaurav Gupta and patient Christopher Cahill

New Brunswick, NJ, August 22, 2017 — MaryLynn Schiavi reports in USA Today that a decade ago, the idea of printing parts of the human body through 3D printing was still in the realm of science fiction.

But on March 28, Dr. Gaurav Gupta, assistant professor of neurosurgery at Rutgers Robert Wood Johnson Medical School, successfully inserted a 3D-printed skull implant into patient Christopher Cahill, of New Brunswick, during a four-hour surgery.

Cahill suffered an injury to the frontal lobe in early 2017 that resulted in life-threatening brain swelling.  After emergency surgery relieved the swelling, Gupta determined that Cahill’s skull was unusable because of an infection in the skull. Continue reading

Trump Signs FDA User Fee Agreement into Law; PhRMA and BIO Applaud the Move

Washington, DC, August 21, 2017 — President Donald J. Trump on Friday signed into law a funding package for the Food and Drug Administration (FDA) that also takes steps to lower drug prices.

The FDA Reauthorization Act (FDARA) of 2017 reauthorizes a program in which drug and medical device makers pay the FDA a fee for every new product application.  The agency uses those funds to hire more people and speed up approvals.

The user fee program must be reauthorized every five years. The current program expires at the end of September, and if it hadn’t been signed into law before then, the agency would have had to lay off workers. Continue reading

Trump Administration Unveils First Blueprint for Federal Investment in Science and Tech; Departs from Its Budget Request

President Donald Trump

Washington, DC, August 21, 2017 — Jeffrey Mervis reports in Science that President Donald J. Trump on August 17 translated his campaign promise to “make America great again” into his administration’s first blueprint for federal investment in science and technology.

The White House on issued a four-page memo telling federal agencies that their research dollars should be focused on delivering short-term dividends in strengthening national defense and border security, the economy, and “energy dominance,” as well as improving public health. Continue reading